Mulpleta is used to treat people with chronic liver disease and certain blood disorders (low platelet levels) who are planning surgery or minor surgery. Having a low platelet count increases the risk of excessive bleeding during certain procedures. Mulpleta increases the body's production of platelets to help prevent excessive bleeding from the procedure.

When the bone marrow is overactive and produces an excessive number of platelets and enters the bloodstream, it will cause a number of dangerous blood-clotting disorders, increasing the risk of unwanted blood clots. Therefore, the drug Agrylin is indicated in the treatment of thrombocytopenia to help limit this condition.

Eltrombopag is a film-coated tablet with the main ingredient Eltrombopag. The drug is indicated for use in the treatment of a number of blood abnormalities: low platelet levels, aplastic anemia, ...